Cell Reprogramming & Therapeutics develops cell reprogramming technologies to treat central nervous system diseases.
Cell Reprogramming & Therapeutics has raised $75K in total funding. The most recent round was Grant. The last funding was announced in June 2022.
Cell Reprogramming & Therapeutics's investors include National Science Foundation, SBIR Advance.
Cell Reprogramming & Therapeutics is headquartered in Wauwatosa, United States.
Cell Reprogramming & Therapeutics develops cell reprogramming technologies to treat central nervous system diseases.
Cell Reprogramming & Therapeutics is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Cell Reprogramming & Therapeutics — Funding & Investors." VCBacked, June 7, 2022, https://www.vcbacked.co/company/cell-reprogramming-therapeutics. Accessed August 15, 2026.
VCBacked. (2022). Cell Reprogramming & Therapeutics — Funding & Investors. Retrieved August 15, 2026, from https://www.vcbacked.co/company/cell-reprogramming-therapeutics
{{cite web |title=Cell Reprogramming & Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/cell-reprogramming-therapeutics |website=VCBacked |access-date=August 15, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated